These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 744072)

  • 1. The biphasic regulation of prolactin secretion by dopamine agonist-antagonists.
    MacLeod RM; Lamberts SW
    Endocrinology; 1978 Jul; 103(1):200-3. PubMed ID: 744072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of prolactin synthesis and release by the administration of monoaminergic blocking agents to pituitary tumor-bearing rats.
    MacLeod RM; Lehmeyer JE
    Cancer Res; 1974 Feb; 34(2):345-50. PubMed ID: 4810907
    [No Abstract]   [Full Text] [Related]  

  • 3. The inhibition of phosphatidylinositol turnover: a possible postreceptor mechanism for the prolactin secretion-inhibiting effect of dopamine.
    Canonico PL; Valdenegro CA; MacLeod RM
    Endocrinology; 1983 Jul; 113(1):7-14. PubMed ID: 6861715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation by dopamine antagonists of DNA synthesis in the pituitary gland of the male rat.
    Jacobi JM; Lloyd HM
    Neuroendocrinology; 1981 Aug; 33(2):97-100. PubMed ID: 7266775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the mechanism of the dopamine-mediated inhibition of prolactin secretion.
    MacLeod RM; Lehmeyer JE
    Endocrinology; 1974 Apr; 94(4):1077-85. PubMed ID: 4818768
    [No Abstract]   [Full Text] [Related]  

  • 6. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro studies on basal and stimulated prolactin release by rat anterior pituitary: a possible role for calmodulin.
    Schettini G; Judd AM; MacLeod RM
    Endocrinology; 1983 Jan; 112(1):64-70. PubMed ID: 6291923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resumption of prolactin secretion after dopaminergic inhibition: differential effects of dopamine and its agonists.
    Woolf PD
    Am J Physiol; 1981 Jun; 240(6):E700-4. PubMed ID: 7246736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic drugs inhibit prolactin release from rat anterior pituitary cells in culture by a mechanism not involving the dopamine receptor.
    West B; Dannies PS
    Endocrinology; 1979 Apr; 104(4):877-80. PubMed ID: 436760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of dopamine and estrogen interaction on primate prolactin secretion with pituitary cells cultured on extracellular matrix and with pituitary stalk-transected monkeys.
    Bethea CL
    Endocrinology; 1985 Mar; 116(3):863-72. PubMed ID: 3882398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic inhibition of pituitary beta-endorphin-like immunoreactivity secretion in the rat.
    Farah JM; Malcolm DS; Mueller GP
    Endocrinology; 1982 Feb; 110(2):657-9. PubMed ID: 6276143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of prolactin gene transcription in vivo: interactions between estrogen, pimozide, and alpha-ergocryptine.
    Shull JD; Gorski J
    Mol Pharmacol; 1990 Feb; 37(2):215-21. PubMed ID: 1968222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of dopamine from tuberoinfundibular neurons into pituitary stalk blood after prolactin or haloperidol administration.
    Gudelsky GA; Porter JC
    Endocrinology; 1980 Feb; 106(2):526-9. PubMed ID: 7353525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine inhibits 32P incorporation into phosphatidylinositol in the anterior pituitary gland of the rat.
    Canonico PL; Valdenegro CA; Macleod RM
    Endocrinology; 1982 Jul; 111(1):347-9. PubMed ID: 7084120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic stimulation of prolactin release.
    Denef C; Manet D; Dewals R
    Nature; 1980 May; 285(5762):243-6. PubMed ID: 6154895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cyproheptadine on prolactin synthesis and release by normal and suppressed pituitary glands and by dispersed pituitary tumor cells.
    Lamberts SW; MacLeod RM
    Endocrinology; 1978 Nov; 103(5):1710-7. PubMed ID: 748012
    [No Abstract]   [Full Text] [Related]  

  • 17. Normal and adenomatous human pituitaries secrete thyrotropin-releasing hormone in vitro: modulation by dopamine, haloperidol, and somatostatin.
    Le Dafniet M; Lefebvre P; Barret A; Mechain C; Feinstein MC; Brandi AM; Peillon F
    J Clin Endocrinol Metab; 1990 Aug; 71(2):480-6. PubMed ID: 1974264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indirect evidence to suggest that prolactin mediates the adrenal action of haloperidol to stimulate aldosterone and corticosterone secretion in rats.
    Goebel S; Dietrich M; Jarry H; Wuttke W
    Endocrinology; 1992 Feb; 130(2):914-9. PubMed ID: 1310283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the role of dopamine receptors in the central regulation of human TSH.
    Delitala G; Devilla L; Canessa A; D'Asta F
    Acta Endocrinol (Copenh); 1981 Dec; 98(4):521-7. PubMed ID: 7304078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction of the serotonergic and dopaminergic systems on prolactin secretion in the rat. The mechanism of action of the "specific" serotonin receptor antagonist, methysergide.
    Lamberts SW; MacLeod RM
    Endocrinology; 1978 Jul; 103(1):287-95. PubMed ID: 744080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.